Free Trial
NASDAQ:CMPS

COMPASS Pathways (CMPS) Stock Price, News & Analysis

COMPASS Pathways logo
$3.27 -0.11 (-3.31%)
As of 11:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About COMPASS Pathways Stock (NASDAQ:CMPS)

Key Stats

Today's Range
$3.26
$3.47
50-Day Range
$2.35
$4.80
52-Week Range
$2.25
$8.54
Volume
848,059 shs
Average Volume
1.22 million shs
Market Capitalization
$305.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Moderate Buy

Company Overview

COMPASS Pathways Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

CMPS MarketRank™: 

COMPASS Pathways scored higher than 40% of companies evaluated by MarketBeat, and ranked 726th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    COMPASS Pathways has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    COMPASS Pathways has only been the subject of 3 research reports in the past 90 days.

  • Read more about COMPASS Pathways' stock forecast and price target.
  • Earnings Growth

    Earnings for COMPASS Pathways are expected to grow in the coming year, from ($2.33) to ($1.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of COMPASS Pathways is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of COMPASS Pathways is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    COMPASS Pathways has a P/B Ratio of 1.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about COMPASS Pathways' valuation and earnings.
  • Percentage of Shares Shorted

    5.89% of the float of COMPASS Pathways has been sold short.
  • Short Interest Ratio / Days to Cover

    COMPASS Pathways has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in COMPASS Pathways has recently increased by 9.30%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    COMPASS Pathways does not currently pay a dividend.

  • Dividend Growth

    COMPASS Pathways does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.89% of the float of COMPASS Pathways has been sold short.
  • Short Interest Ratio / Days to Cover

    COMPASS Pathways has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in COMPASS Pathways has recently increased by 9.30%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    COMPASS Pathways has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for COMPASS Pathways this week, compared to 3 articles on an average week.
  • Search Interest

    9 people have searched for CMPS on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added COMPASS Pathways to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, COMPASS Pathways insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.93% of the stock of COMPASS Pathways is held by insiders.

  • Percentage Held by Institutions

    46.19% of the stock of COMPASS Pathways is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about COMPASS Pathways' insider trading history.
Receive CMPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COMPASS Pathways and its competitors with MarketBeat's FREE daily newsletter.

CMPS Stock News Headlines

Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

CMPS Stock Analysis - Frequently Asked Questions

COMPASS Pathways' stock was trading at $3.78 at the beginning of the year. Since then, CMPS shares have decreased by 12.8% and is now trading at $3.2950.
View the best growth stocks for 2025 here
.

COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) released its quarterly earnings results on Thursday, May, 8th. The company reported ($0.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.03.
Read the conference call transcript
.

COMPASS Pathways (CMPS) raised $100 million in an initial public offering on Friday, September 18th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. Cowen, Evercore ISI and Berenberg served as the underwriters for the IPO and Canaccord Genuity was co-manager.

Shares of CMPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that COMPASS Pathways investors own include Symbotic (SYM), Enovix (ENVX), Rambus (RMBS), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Ginkgo Bioworks (DNA), Toast (TOST) and Saia (SAIA).

Company Calendar

Last Earnings
5/08/2025
Today
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CMPS
Fax
N/A
Employees
120
Year Founded
2016

Price Target and Rating

Average Stock Price Target
$17.00
High Stock Price Target
$45.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+403.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$155.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.26 per share
Price / Book
1.50

Miscellaneous

Free Float
89,885,000
Market Cap
$316.23 million
Optionable
Optionable
Beta
2.12

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CMPS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners